BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19429477)

  • 21. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
    Koturbash I; Beland FA; Pogribny IP
    Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and typing of human papillomavirus nucleic acids in biological fluids.
    Coutlée F; Mayrand MH; Roger M; Franco EL
    Public Health Genomics; 2009; 12(5-6):308-18. PubMed ID: 19684443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
    Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
    J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Alterations in Human Papillomavirus-Associated Cancers.
    Soto D; Song C; McLaughlin-Drubin ME
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28862667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis.
    Lou Z; Wang S
    J Int Med Res; 2014 Apr; 42(2):247-60. PubMed ID: 24445694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.
    Gupta SM; Mania-Pramanik J
    J Biomed Sci; 2019 Apr; 26(1):28. PubMed ID: 31014351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epigenetic alterations in cervical cancer progression].
    Ríos-Romero M; Soto-Valladares AG; Piña-Sánchez P
    Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S212-7. PubMed ID: 26462519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet.
    Pogribny IP; Shpyleva SI; Muskhelishvili L; Bagnyukova TV; James SJ; Beland FA
    Mutat Res; 2009 Oct; 669(1-2):56-62. PubMed ID: 19442675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
    van der Kwast TH; Bapat B
    Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
    Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells.
    Qiao Y; Cao J; Xie L; Shi X
    Arch Pharm Res; 2009 Sep; 32(9):1309-15. PubMed ID: 19784588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic mechanisms in the biology of prostate cancer.
    Schulz WA; Hoffmann MJ
    Semin Cancer Biol; 2009 Jun; 19(3):172-80. PubMed ID: 19429481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary on: Statement on HPV DNA test utilization.
    Cox JT; Moriarty AT; Castle PE
    J Low Genit Tract Dis; 2009 Jul; 13(3):131-4. PubMed ID: 19550208
    [No Abstract]   [Full Text] [Related]  

  • 39. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
    Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus early gene products and maintenance of the transformed state of cervical cancer cells in vitro.
    Kleinheinz A; von Knebel Doeberitz M; Cripe TP; Turek LP; Gissmann L
    Curr Top Microbiol Immunol; 1989; 144():175-9. PubMed ID: 2551582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.